Clinical Trials Browser

Active not recruiting × Carcinoma, Hepatocellular × Sorafenib × Clear all

NCT04039607 2026-04-06

CheckMate 9DW

Phase 3 Active not recruiting

732 enrolled 2 FDA

Gastrointestinal

Carcinoma, Hepatocellular

NCT03298451 2026-03-20

HIMALAYA

Phase 3 Active not recruiting

1,324 enrolled 31 charts 2 FDA

Gastrointestinal

Carcinoma, Hepatocellular

NCT03755791 2025-12-11

COSMIC-312

Phase 3 Active not recruiting

837 enrolled 14 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT05822752 2025-08-14

LIVIGNO-1

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT01840592 2025-05-02

Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT03017326 2024-05-13

PHITT

Phase 3 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma